4//SEC Filing
Talon Therapeutics, Inc. 4
Accession 0000914190-13-000430
CIK 0001140028operating
Filed
Jul 17, 8:00 PM ET
Accepted
Jul 18, 4:13 PM ET
Size
14.1 KB
Accession
0000914190-13-000430
Insider Transaction Report
Form 4
CARLSON CRAIG W
Chief Financial Officer
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2013-07-17−400,000→ 0 totalExercise: $0.64Exp: 2023-01-25→ Common Stock (400,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2013-07-17−705,000→ 0 totalExercise: $0.49Exp: 2020-12-21→ Common Stock (705,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2013-07-17−87,500→ 0 totalExercise: $0.76Exp: 2020-03-01→ Common Stock (87,500 underlying) - Disposition to Issuer
Stock Option (right to buy)
2013-07-17−400,000→ 0 totalExercise: $0.91Exp: 2022-02-17→ Common Stock (400,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2013-07-17−62,500→ 0 totalExercise: $0.92Exp: 2020-06-07→ Common Stock (62,500 underlying)
Footnotes (1)
- [F1]This stock option was cancelled pursuant to the terms of a Stock Purchase Agreement by and among Talon Therapeutics, Inc., Spectrum Pharmaceuticals, Inc. and Eagle Acquisition Merger Sub, Inc. dated July 16, 2013.
Documents
Issuer
Talon Therapeutics, Inc.
CIK 0001140028
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001140028
Filing Metadata
- Form type
- 4
- Filed
- Jul 17, 8:00 PM ET
- Accepted
- Jul 18, 4:13 PM ET
- Size
- 14.1 KB